Anavex Life Sciences Corp.
AVXL:NASDAQ
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) and high risk CNS patient populations (Parkinson's Disease, Alzheimer's Disease).
Streetwise Company Fact Sheet2025/4/16 5:38:53
(AVXL:NASDAQ)
Analyst coverage
| D. Boral Capital — Jason Kolbert |
| Jones Trading — Dr. Sounmit Roy |
| H.C. Wainwright & Co. — Dr. Ram Selvaraju |
| H.C. Wainwright & Co. — Raghuram Selvaraju |
Streetwise Reports Articles
| 04/09/2025 - View Article |
| 04/09/2025 - View Article |
| 04/07/2025 - View Article |
| 10/18/2024 - View Article |
Streetwise - Anavex Life Sciences Corp. Ownership Overview*
Anavex Life Sciences Corp. (AVXL:NASDAQ)
*Share Structure as of 4/7/2025
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
